Revolutionary Vaccines for RSV (Respiratory Syncytial Virus): A Breakthrough in Treatment
2023-09-10 17:34:12 RSV (respiratory syncytial virus), the cause of bronchiolitis, already has three vaccines approved in recent weeks in Europe and the United States. asiraj – stock.adobe.com The market for treatment against RSV (respiratory syncytial virus), the cause of bronchiolitis, could ultimately reach $10 to $12 billion per year. Three years after Covid, this is … Read more